UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Total revenue	$ 800.7	$ 681.9	$ 1,522.4	$ 1,367.2
Total cost of revenue	416.1	341.4	785.0	667.0
Gross profit	384.6	340.5	737.4	700.2
Operating expenses:
Selling, general and administrative	221.3	177.9	416.6	340.6
Research and development	92.2	71.0	174.0	140.0
Other charges, net	23.0	5.4	33.9	10.7
Total operating expenses	336.5	254.3	624.5	491.3
Operating income	48.1	86.2	112.9	208.9
Interest and other income (expense), net	(24.2)	(8.7)	(17.4)	(24.8)
Income before income taxes, equity in income of unconsolidated investees, net of tax, and noncontrolling interests in consolidated subsidiaries	23.9	77.5	95.5	184.1
Income tax provision	16.1	19.9	35.9	49.8
Equity in income (losses) of unconsolidated investees, net of tax	(0.2)	0.2	0.0	0.9
Net income	7.6	57.8	59.6	135.2
Net income attributable to noncontrolling interests in consolidated subsidiaries	0.0	0.7	1.1	1.6
Net income attributable to Bruker Corporation	$ 7.6	$ 57.1	$ 58.5	$ 133.6
Net income per common share attributable to Bruker Corporation shareholders:
Basic	$ 0.05	$ 0.39	$ 0.4	$ 0.91
Diluted	$ 0.05	$ 0.39	$ 0.4	$ 0.91
Weighted average common shares outstanding:
Basic	147.4	146.8	146.3	146.8
Diluted	148	147.7	147	147.6
Product
Total revenue	$ 654.4	$ 559.6	$ 1,241.3	$ 1,126.7
Total cost of revenue	326.0	272.8	617.7	530.0
Other
Total revenue	146.3	122.3	281.1	240.5
Total cost of revenue	$ 90.1	$ 68.6	$ 167.3	$ 137.0